Dovitinib multi target TKI
Description Results

CHIR-258 - CHIR258 - CHIR 258 - dovitinib - TKI-258 - TKI258 - TKI 258      

  • Group by...

pdf
pathology Benefit (demonstrated or suggested) and harm      
renal-cell carcinoma (advanced)

All results are NS for efficacy

meta-analysis



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons